DR info

Clinical trials : 43 / Drugs : 52 - (DrugBank : 15) / Drug target genes : 28 - Drug target pathways : 26

West syndrome and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)

ID	Diseases (Sorted by score)	Score
145	West syndrome	-
2	Amyotrophic lateral sclerosis	23.417
6	Parkinson disease	23.394
13	Multiple sclerosis/Neuromyelitis optica	23.322
144	Lennox-Gastaut syndrome	22.639
8	Huntington disease	22.095
46	Malignant rheumatoid arthritis	20.016
140	Dorabe syndrome	19.793
97	Ulcerative colitis	18.553
206	Fragile X syndrome	16.735
158	Tuberous sclerosis	16.426
205	Fragile X syndrome related disease	16.320
156	Rett syndrome	16.162
152	PCDH19 related syndrome	16.000
193	Prader-Willi syndrome	15.468
298	Hereditary pancreatitis	15.389
98	Eosinophilic gastrointestinal disease	14.634
18	Spinocerebellar degeneration	14.400
201	Angelman syndrome	14.222
36	Epidermolysis bullosa	14.204
3	Spinal muscular atrophy	14.038
96	Crohn disease	14.007
75	Cushing disease	13.742
272	Fibrodysplasia ossificans progressiva	13.493
84	Sarcoidosis	13.317
22	Moyamoya disease	13.206
296	Biliary atresia	13.082
155	Acquired aphasia with convulsive disorder	13.078
21	Mitochondrial disease	12.981
231	Alpha-1-antitrypsin deficiency	12.461
17	Multiple system atrophy	12.458
5	Progressive supranuclear palsy	12.350
70	Spinal stenosis	12.325
34	Neurofibromatosis	11.934
149	Hemiconvulsion hemiplegia epilepsy syndrome	2.980
49	Systemic lupus erythematosus	1.105
202	Smith-Magenis syndrome	1.074
220	Rapidly progressive glomerulonephritis	1.000
30	Distal myopathy	1.000